Search Results - "Ruggiero, Salvatore L."

Refine Results
  1. 1

    American Association of Oral and Maxillofacial Surgeons’ Position Paper on Medication-Related Osteonecrosis of the Jaws—2022 Update by Ruggiero, Salvatore L., Dodson, Thomas B., Aghaloo, Tara, Carlson, Eric R., Ward, Brent B., Kademani, Deepak

    Published in Journal of oral and maxillofacial surgery (01-05-2022)
    “…Strategies for management of patients with, or at risk for, medication-related osteonecrosis of the jaws (MRONJ) – formerly referred to as…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Disease Stage and Mode of Therapy Are Important Determinants of Treatment Outcomes for Medication-Related Osteonecrosis of the Jaw by Ruggiero, Salvatore L., DMD, MD, Kohn, Nina, MBA, MA

    Published in Journal of oral and maxillofacial surgery (01-12-2015)
    “…Purpose The treatment of patients with medication-related osteonecrosis of the jaw (MRONJ) is challenging. The purpose of the present study was to estimate the…”
    Get full text
    Journal Article
  5. 5

    Bisphosphonate-related osteonecrosis of the jaw: an overview by Ruggiero, Salvatore L.

    Published in Annals of the New York Academy of Sciences (01-02-2011)
    “…Bisphosphonates are widely used in the management of metastatic disease to bone and in diseases of altered bone turnover. Recently, multiple‐case series and…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw by Ruggiero, Salvatore L., DMD, MD

    “…The relationship between osteonecrosis of the jaw and bisphosphonate therapy was initially established more than 10 years ago. Since that time our…”
    Get full text
    Journal Article
  8. 8

    Pathophysiology of Medication‐Related Osteonecrosis of the Jaw—A Minireview by Tetradis, Sotirios, Allen, Matthew R., Ruggiero, Salvatore L.

    Published in JBMR plus (01-08-2023)
    “…ABSTRACT Medication‐related osteonecrosis of the jaw (MRONJ) is a rare but serious adverse effect of antiresorptive medications administered for control of…”
    Get full text
    Journal Article
  9. 9

    Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management by Ruggiero, Salvatore L, Mehrotra, Bhoomi

    Published in Annual review of medicine (01-01-2009)
    “…Bisphosphonate therapy has been considered standard therapy in the management and care of cancer patients with metastatic bone disease and patients with…”
    Get full text
    Journal Article
  10. 10

    Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ): Initial Discovery and Subsequent Development by Ruggiero, Salvatore L., DMD, MD

    Published in Journal of oral and maxillofacial surgery (01-05-2009)
    “…The efficacy of bisphosphonates in controlling skeletally related events in cancer patients and fractures in osteoporotic patients coupled with a relatively…”
    Get full text
    Journal Article
  11. 11

    A review of pharmaceutical agents and oral bone health: how osteonecrosis of the jaw has affected the field by Allen, Matthew R, Ruggiero, Salvatore L

    “…Just a decade ago, the outlook appeared limitless for the use of bisphosphonates for the treatment of a large number of metabolic bone diseases ranging from…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14

    Metastatic Cancer Identified in Osteonecrosis Specimens of the Jaws in Patients Receiving Intravenous Bisphosphonate Medications by Carlson, Eric R., DMD, MD, Fleisher, Kenneth E., DDS, Ruggiero, Salvatore L., DMD, MD

    Published in Journal of oral and maxillofacial surgery (01-12-2013)
    “…Purpose The aim of the present study was to investigate the microscopic presence of metastatic cancer in jaw specimens clinically and histologically diagnosed…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Emerging Concepts in the Management and Treatment of Osteonecrosis of the Jaw by Ruggiero, Salvatore L., DMD, MD

    “…Since the first description of bone necrosis in patients receiving bisphosphonate therapy in 2004, there have been multiple retrospective, prospective, and…”
    Get full text
    Journal Article
  17. 17

    Absence of Exposed Bone Following Dental Extraction in Beagle Dogs Treated With 9 Months of High-Dose Zoledronic Acid Combined With Dexamethasone by Allen, Matthew R., PhD, Chu, Tien-Min Gabriel, PhD, Ruggiero, Salvatore L., DMD, MD

    Published in Journal of oral and maxillofacial surgery (01-06-2013)
    “…Purpose Factors contributing to osteonecrosis of the jaw with anti-remodeling drug treatment are unclear. Epidemiologic and experimental studies have suggested…”
    Get full text
    Journal Article
  18. 18

    Bisphosphonate osteonecrosis of the jaw: A historical and contemporary review by McLeod, Niall M.H, Brennan, Peter A, Ruggiero, Salvatore L

    Published in The surgeon (Edinburgh) (01-02-2012)
    “…Abstract The use of bisphosphonate drugs has been popularised in the late 20th century for the management of many conditions associated with abnormalities of…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Biophosphonate-Related Osteonecrosis of the Jaws by Ruggiero, Salvatore L., DMD, MD, Woo, Sook-Bin, DMD, MMSc

    “…In 2003 and 2004, the first reports of patients who developed necrosis of the jawbones while taking biophosphonates appeared in literature; most patients were…”
    Get full text
    Journal Article